Literature DB >> 6967787

Natural killing in systemic lupus erythematosus: inhibitory effects of serum.

S L Silverman, E S Cathcart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6967787     DOI： 10.1016/0090-1229(80)90090-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  12 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

3.  Effects of ultraviolet irradiation on natural killer cell function in systemic lupus erythematosus.

Authors:  O Nived; I Johansson; G Sturfelt
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

4.  Lysosomal enzymes and metabolic activity of polymorphonuclear leukocytes from patients with systemic lupus erythematosus and from experimental animals after levamisole treatment.

Authors:  M Ferencík; J Rovenský; J Stefanovic
Journal:  Agents Actions       Date:  1982-10

5.  Suppressed natural killer cell activity during episodes of erythema nodosum leprosum in lepromatous leprosy.

Authors:  R C Humphres; R H Gelber; J L Krahenbuhl
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

6.  Natural killer cells and interferon responses in patients with systemic lupus erythematosus.

Authors:  G C Tsokos; A H Rook; J Y Djeu; J E Balow
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

7.  Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.

Authors:  P A Neighbour; A I Grayzel; A E Miller
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.

Authors:  J D Gray; A Lash; A C Bakke; R C Kitridou; D A Horwitz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

9.  Deficient spontaneous cell-mediated cytotoxicity and lectin-induced cellular cytotoxicity by peripheral blood mononuclear cells from Thai adults naturally infected with malaria.

Authors:  M J Gilbreath; K Pavanand; R P MacDermott; P Phisphumvithi; B Permpanich; T Wimonwattrawatee
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

10.  Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Authors:  A Yamada; J B Winfield
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.